	Label	Description
	G43417UB Compound (Entity type)	type="BaseComposition" mass="383.142760805" permass="495.267961365" monosaccharides="2" is_motif="Fa...
	G16407EV Compound (Entity type)	type="BaseComposition" mass="1380.49133628" permass="1730.88258803" monosaccharides="8" is_motif="Fa...
	LYVE1 HUMAN Protein (Entity type)	Lymphatic vessel endothelial hyaluronic acid receptor 1 (precursor)
	q9y5y7-1 289asn 289asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	q9y5y7-1 216thr 216thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

G43417UB

type="BaseComposition" mass="383.142760805" permass="495.267961365" monosaccharides="2" is_motif="Fa...

G16407EV

type="BaseComposition" mass="1380.49133628" permass="1730.88258803" monosaccharides="8" is_motif="Fa...

LYVE1 HUMAN

Lymphatic vessel endothelial hyaluronic acid receptor 1 (precursor)

q9y5y7-1 289asn 289asn defined go:0006486 go:0006487

A Post Translational Modification

q9y5y7-1 216thr 216thr defined go:0006486 go:0006493

A Post Translational Modification

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.